Cancer Journal: A table of contents

I am a psychologist, a health services researcher, and a contributor to The Incidental Economist. The Cancer Journal reports my experiences as a cancer patient in the COVID pandemic. “I have serious news.” My day and night in the Emergency Department on July 2nd and […]

Covid Vaccine Month of Action

The Biden administration has announced a new a goal when it comes to Covid-19 vaccinations in the US: It aims for at least 70% of Americans to receive at least one dose by July 4th. The current administration has announced a plan and lots of […]

Breaking Down House Democrats’ Forthcoming Competition Bills

Democratic leadership of the House Judiciary Committee have leaked the approach they plan to take to revise U.S. antitrust law and enforcement, with a particular focus on digital platforms. Broadly speaking, the bills would: raise fees for larger mergers and increase appropriations to the FTC […]

ITSA Foreshadows Final Act in 5.9GHz Fight

It’s a telecom tale as old as time: industry gets a prime slice of radio spectrum and falls in love with it, only to take it for granted. Then, faced with the reapportionment of that spectrum, it proceeds to fight tooth and nail (and law […]

Bad Blood at the FTC

John Carreyrou’s marvelous book Bad Blood chronicles the rise and fall of Theranos, the one-time Silicon Valley darling that was revealed to be a house of cards.[1] Theranos’s Svengali-like founder, Elizabeth Holmes, convinced scores of savvy business people (mainly older men) that her company was […]

The Proposed Hospital Mega-Merger in Rhode Island Shouldn’t Happen

The two largest hospital systems in Rhode Island, Lifespan and Care New England (CNE), submitted an application to the state in April to form a new health system in partnership with Brown University.* In spite of proponents’ claims to the contrary, this mega-merger would likely […]

Against the Jones Act

Economist Josh Hendrickson asserts that the Jones Act is properly understood as a Coasean bargain. In this view, the law serves as a subsidy to the U.S. maritime industry through its restriction of waterborne domestic commerce to vessels that are constructed in U.S. shipyards, U.S.-flagged, […]

Buprenorphine Regulations and Better Treatment of Addiction

We face a lot of obstacles on the road to ending the opioid crisis, and one of them revolves around access to evidence-based addiction treatments. The X-waiver, a waiver physicians must obtain to prescribe the partial opioid agonist Buprenorphine, is one of them. New regulations […]

Paid sick leave is a women’s health issue

Cecille Joan Avila is a policy analyst at Boston University School of Public Health. She tweets @cecilleavila. Paid family and medical leave has been the main focus lately, but paid sick leave is equally important. I talk more about its importance and why it matters […]

Overdiagnosis and overtreatment: the provider perspective

Elsa Pearson, MPH, is a senior policy analyst at Boston University School of Public Health. She tweets at @epearsonbusph. Research for this piece was supported by the Laura and John Arnold Foundation. Overdiagnosis and overtreatment are widespread practices in the US health care system. Providers […]